Vanessa Jacoby, MD, MAS
Professor
Ob/Gyn, Reproductive Sciences
School of Medicine

Dr. Vanessa Jacoby is a Professor of Obstetrics, Gynecology, and Reproductive Sciences, the Associate Vice Chancellor for Clinical Research, and Director of the Clinical and Translational Science Institute. She is a clinical researcher with a focus on improving care for people with uterine fibroids.

Show full bio (210 words) Hide full bio

She has conducted multiple clinical trials of new, minimally invasive treatments for people with fibroids including MR Guided Focused Ultrasound, laparoscopic radiofrequency ablation, and aromatase inhibitors. Dr. Jacoby's work has also focused on long-term health outcomes following hysterectomy and oophorectomy, particularly for people who are carriers of BRCA1 or BRCA2 pathogenic variants who undergo risk-reducing salpingo-oophorectomy.

With the onset of COVID-19, Dr. Jacoby worked with a multi-disciplinary group of collaborators to launch the PRIORITY study, a nationwide study of pregnant people and their newborns with COVID-19 (priority.ucsf.edu). Analyses from PRIORITY identified the persistence of COVID-19 symptoms in 25% of people infected during pregnancy. This work has led to further study of long-term outcomes following COVID-19 infection during pregnancy in the RECOVER study (recovercovid.org).

Dr. Jacoby’s research has been driven by patient-centered outcomes, community partnerships, and recruitment of underrepresented study populations. She is the director of the CTSI Participant Recruitment Program (recruit.ucsf.edu) to support recruitment of diverse populations into clinical studies across UCSF. She is also a dedicated mentor involved in many research training programs at UCSF including the CTSI K Scholars Program, the K12 Women's Reproductive Health Research Program (WRHR), and the ARCHES program for faculty from historically excluded groups (archesprogram.ucsf.edu).

Education & Training

Show all (6) Hide

  • Diversity, Equity, and INclusion Training University of California 2022
  • MAS Clinical Research University of California 2007
  • Fellowship Women's Health Research University of California 2007
  • Residency Obstetrics and Gynecology University of California 2005
  • MD Medicine University of California 2001
  • BA Geography University of California 1995

Interests

Show all (4) Hide

  • uterine fibroids
  • oophorectomy
  • COVID-19
  • hysterectomy

Websites

Show all (5) Hide

Grants and Projects

Show all (18) Hide

  • NIH 1R01HD112465-01, Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial, 2023-2028
  • NIH R01HD10912, Long-Term Outcomes following Uterine Sparing Procedures, 2023-2027
  • NIH K12 HD001262, Women's Reproductive Health Research Career Development Program, 2020-2025
  • NIH OT2HL161847, Researching COVID to Enhance Recovery (RECOVER) Initiative, 2021-2025
  • Acessa Health A121285, Uterine Leiomyoma Treatment with Radiofrequency Ablation, 2018-2024
  • NIH R44HD102235, A Photo-based Menstrual Blood Loss Metric, 2021-2024
  • YellowChair Foundation, Pregnancy Coronavirus Outcomes Registry, 2020-2022
  • Robert Wood Johnson Foundation A135564, Amplifying Perspectives on Healthcare, Policy, and Research from those most impacted by COVID-19, 2020-2021
  • CDC Foundation A135129, PRIORITY: Supporting the Public Health Response to COVID-19, 2020-2021
  • California Healthcare Foundation A135146, Pregnancy Coronavirus Outcomes Registry (PRIORITY), 2020-2021
  • Patient Centered Outcomes Research Institute (PCORI)/AHRQ P500HS023418-05, Comparing Options for Management: Patient-Centered Results for Uterine Fibroids (COMPARE-UF), 2015-2020
  • American Cancer Society RSG-13-166-01, Oophorectomy in Women with BRCA: Cardiac Risk, Bone Health, Quality of Life, 2013-2019
  • Patient Centered Outcomes Research Institute (PCORI), Community Engaged Network for All (CENA), 2014-2018
  • NIH R44CA121740-02, Minimally Invasive High Intensity Ultrasound Treatment of Uterine Fibroids, 2014-2016
  • The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies, NIH R01 HD060053, 2013-2016
  • NIH R01HD060053, The FIRSTT Trial: Assessing Outcomes of minimally Invasive Leiomyoma Therapies, 2013-2016
  • NIH R21CA141241, Development and Pilot Test of Elective BSO Decision Support Guide, 2009-2012
  • NIH K12HD001262, Bilateral Oophorectomy versus Ovarian Conservation at the time of Hysterectomy, 2007-2012

Publications (63)

Top publication keywords:
OvariectomyLaparoscopyUterine ProlapseUterine Artery EmbolizationHysterectomySex Reassignment ProceduresUterine DiseasesLeiomyomaUterine NeoplasmsAbortion, SpontaneousUterine MyomectomyOvarian NeoplasmsGynecologic Surgical ProceduresOrgan Sparing TreatmentsEndometrium

Show all (58 more) Hide